Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John Girdlestone is active.

Publication


Featured researches published by John Girdlestone.


Nature Genetics | 1999

A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection

Emmanuelle Jouanguy; Salma Lamhamedi-Cherradi; David A. Lammas; Susan E. Dorman; Marie Claude Fondanèche; Stéphanie Dupuis; Rainer Döffinger; Frédéric Altare; John Girdlestone; Jean-François Emile; Henri Ducoulombier; David Edgar; Jane Clarke; Vivi Anne Oxelius; Melchiorre Brai; Vas Novelli; Klaus Heyne; Alain Fischer; Steven M. Holland; Dinakantha Kumararatne; Robert D. Schreiber; Jean-Laurent Casanova

The immunogenetic basis of severe infections caused by bacille Calmette-Guérin vaccine and environmental mycobacteria in humans remains largely unknown. We describe 18 patients from several generations of 12 unrelated families who were heterozygous for 1 to 5 overlapping IFNGR1 frameshift small deletions and a wild-type IFNGR1 allele. There were 12 independent mutation events at a single mutation site, defining a small deletion hotspot. Neighbouring sequence analysis favours a small deletion model of slipped mispairing events during replication. The mutant alleles encode cell-surface IFNγ receptors that lack the intra-cytoplasmic domain, which, through a combination of impaired recycling, abrogated signalling and normal binding to IFNγ exert a dominant-negative effect. We thus report a hotspot for human IFNGR1 small deletions that confer dominant susceptibility to infections caused by poorly virulent mycobacteria.


Journal of Clinical Investigation | 1998

Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection.

Frédéric Altare; David A. Lammas; Patrick Revy; Emmanuelle Jouanguy; Rainer Döffinger; Salma Lamhamedi; Pamela Drysdale; D Scheel-Toellner; John Girdlestone; P Darbyshire; M Wadhwa; H Dockrell; M Salmon; Alain Fischer; Anne Durandy; Jean-Laurent Casanova; Dinakhanta S. Kumararatne

Interferon-gamma receptor ligand-binding chain (IFN-gammaR1) or signaling chain (IFN-gammaR2) deficiency, like interleukin 12 receptor beta1 chain (IL-12Rbeta1) deficiency, predispose to severe infections due to poorly virulent mycobacteria and salmonella. A child with bacille Calmette-Guérin and Salmonella enteritidis infection was investigated. Mutations in the genes for IFN-gammaR1, IFN-gammaR2, IL-12Rbeta1, and other molecules implicated in IL-12- or IFN-gamma-mediated immunity were sought. A large homozygous deletion within the IL-12 p40 subunit gene was found, precluding expression of functional IL-12 p70 cytokine by activated dendritic cells and phagocytes. As a result, IFN-gamma production by lymphocytes was markedly impaired. This is the first discovered human disease resulting from a cytokine gene defect. It suggests that IL-12 is essential to and appears specific for protective immunity to intracellular bacteria such as mycobacteria and salmonella.


The Journal of Pathology | 2002

Fractalkine expression in human renal inflammation

Paul Cockwell; Srabasti J. Chakravorty; John Girdlestone; Caroline O. S. Savage

Immune and inflammatory human renal disease is associated with heavy mononuclear cell infiltration. The trafficking of these cells to extravascular sites is directed by local production of chemokines. Fractalkine is the first described cell‐surface anchored chemokine and has potent mononuclear cell‐directed adhesion and chemotactic properties. The purpose of this study was to analyse the expression and distribution of fractalkine in human renal inflammation. In situ hybridization and immunohistochemistry were used to study renal biopsies from 15 patients with predominant glomerular inflammation (vasculitic glomerulonephritis) and 15 with predominant tubular and interstitial inflammation (acute renal allograft rejection). Controls comprised non‐inflammatory glomerulonephritis and normal tissue. Fractalkine mRNA was predominantly expressed in the major compartment, glomerular or tubulointerstitial, affected by disease and with the strongest expression localized to vascular sites local to inflammation. In acute renal allograft rejection, there was increased expression of fractalkine mRNA by tubular epithelial cells. There was no expression of fractalkine by infiltrating leukocytes and there was only sparse expression in control tissue. Fractalkine mRNA expression correlated with infiltrating leukocyte subsets. Immunohistochemistry confirmed this pattern of expression, with serial section co‐localization showing fractalkine expression in areas with macrophage (CD68+) and T cell (CD3+) infiltrates. These expression patterns show that fractalkine is a strong candidate for directing mononuclear cell infiltration in human renal inflammation. Copyright


Clinical and Experimental Immunology | 2002

Fractalkine expression on human renal tubular epithelial cells: potential role in mononuclear cell adhesion

Srabasti J. Chakravorty; Paul Cockwell; John Girdlestone; Christopher J. Brooks; Caroline O. S. Savage

Fractalkine (CX3CL1) is a transmembrane molecule with a CX3C chemokine domain attached to an extracellular mucin stalk which can induce both adhesion and migration of leucocytes. Mononuclear cell infiltration at renal tubular sites and associated tubular epithelial cell damage are key events during acute renal inflammation following renal allograft transplantation. Using northern and Western blot analysis, we have demonstrated the expression of fractalkine message and protein by renal tubular epithelial cells in vitro. The expression was up‐regulated by TNF‐α, a key proinflammatory cytokine in acute rejection. Investigation of surface expression of fractalkine on cultured proximal tubular epithelial cells revealed only a subpopulation of positively staining cells. Immunohistochemistry revealed that only a proportion of tubules in renal allograft biopsies showed induction of fractalkine expression. Studies using a static model of adhesion demonstrated CX3CR1/fractalkine interactions accounted for 26% of monocytic THP‐1 cell and 17% of peripheral blood natural killer cell adhesion to tubular epithelial cells, suggesting that fractalkine may have a functional role in leucocyte adhesion and retention, at selected tubular sites in acute renal inflammation. Thus, fractalkine blockade strategies could reduce mononuclear cell mediated tubular damage and improve graft survival following kidney transplantation.


The Journal of Pathology | 2001

Potential role for monocyte chemotactic protein-4 (MCP-4) in monocyte/macrophage recruitment in acute renal inflammation.

Srabasti J. Chakravorty; Alexander J. Howie; John Girdlestone; Dean Gentle; Caroline O. S. Savage

The CC chemokine, monocyte chemoattractant protein‐4 (MCP‐4), is an important chemoattractant for monocytes and T cells. Recent data indicate a role in renal inflammation. This study has used in situ hybridization and immunohistochemical analysis of cryostat sections of biopsy material taken from patients with acute renal allograft rejection and vasculitic glomerulonephritis to demonstrate renal expression of MCP‐4, both at message and protein level. MCP‐4 was primarily expressed at peritubular, periglomerular, and perivascular sites, irrespective of the inflammatory condition, and was associated with infiltrating CD3‐positive lymphocytes and CD68‐positive monocyte/macrophages. In addition, proximal tubular epithelial cells grown in culture from cortical fragments of human kidney showed low levels of constitutive MCP‐4 expression, detectable by western blotting; this expression of MCP‐4 was up‐regulated in response to the pro‐inflammatory cytokines, tumour necrosis factor‐α (TNF‐α) and interferon‐γ (IFN‐γ). CCR3‐, CCR5‐ and CCR2‐expressing leukocyte populations were identified at sites of MCP‐4 expression. Double‐staining techniques revealed that CC chemokine receptor‐expressing cells were primarily CD68‐positive. These studies suggest an important role for MCP‐4 in the recruitment and retention of monocytes/macrophages in renal inflammation. Copyright


Journal of Immunological Methods | 2001

Protocols for high efficiency, stage-specific retroviral transduction of murine fetal thymocytes and thymic epithelial cells

Helen Travers; Graham Anderson; Dean Gentle; Eric J. Jenkinson; John Girdlestone

Viral vectors have the potential to provide a fast and economic alternative to transgenic methods for manipulating gene expression in studies of immune system development and function. Although protocols exist for the infection of hematopoietic precursors and peripheral T cells in vitro, critical stages of T cell differentiation are strictly dependent upon a three-dimensional thymic architecture and their analysis poses unique technical challenges. Whole fetal thymic lobes have been used as targets for retroviral and adenoviral infection, both in situ and in vitro, but this approach does not allow for discrimination between lymphoid and stromal components. Isolated thymocytes have been infected by co-culture with viral producer cells, but under these conditions they rapidly lose their developmental potential. To overcome these problems we have combined a number of efficient techniques for retroviral production, concentration, and infection that allow us to rapidly achieve significant transduction rates of purified populations of double-negative (DN) and double-positive (DP) thymocytes, single-positive (SP) T lymphocytes, as well as fetal thymic MHC II(+) epithelial cells without the need for co-culture with viral producer cells. Reaggregate thymic organ culture (RTOC) techniques were used to assess the development and function of transduced cells in defined cellular environments. As a demonstration of the utility of these methods, CD80 (B7.1) was transduced into thymic epithelial cells and shown to allow them to mediate negative selection of DP thymocytes, and to act as antigen-presenting cells (APC) to mature T cells. The ability to genetically manipulate primary cells of a specified type and differentiation stage provides a powerful complement to RTOC techniques for the study of T cell development.


European Journal of Immunology | 1998

IFN-α super-induction of HLA class I expression by a variant thymoma cell line involves nuclear translocation of Rel complexes

Helen Travers; John Girdlestone

Variant thymoma lines have been described which exhibit a substantially increased level of HLA class I induction by IFN‐α, but not by IFN‐γ, and an unchanged response of other IFN‐α‐stimulated genes (Burrone et al., EMBO J. 1985. 4: 2855 – 2860). We report that their amplified response correlates with the nuclear translocation of Rel transcription factors upon prolonged treatment with IFN‐α. The variant cells contain an IκBα subset with a significantly shortened half‐life, and a constitutively active form of IκBα efficiently blocks HLA class I induction. Therefore, in addition to STAT‐mediated induction, prolonged exposure to IFN‐α can affect transcription involving Rel factors, which are implicated in the regulation of numerous immune response and viral genes.


European Journal of Immunology | 1999

Interferon-β mediates stromal cell rescue of T cells from apoptosis

Darrell Pilling; Arne N. Akbar; John Girdlestone; C. H. Orteu; Nicola J. Borthwick; Nicole Amft; Dagmar Scheel-Toellner; Christopher D. Buckley; Mike Salmon


European Journal of Immunology | 1996

Autocrine activation by interferon-γ of STAT factors following T cell activation

John Girdlestone; Mark Wing


Blood | 2000

Synergistic induction of HLA class I expression by RelA and CIITA.

John Girdlestone

Collaboration


Dive into the John Girdlestone's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Srabasti J. Chakravorty

Liverpool School of Tropical Medicine

View shared research outputs
Top Co-Authors

Avatar

Dean Gentle

University of Birmingham

View shared research outputs
Top Co-Authors

Avatar

Helen Travers

University of Birmingham

View shared research outputs
Top Co-Authors

Avatar

Mark Wing

University of Cambridge

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paul Cockwell

University of Birmingham

View shared research outputs
Top Co-Authors

Avatar

Rainer Döffinger

National Institute for Health Research

View shared research outputs
Top Co-Authors

Avatar

Alain Fischer

Necker-Enfants Malades Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge